Steroid Tapering Guidelines

Introduction to Tapering

The American College of Physicians recommends that for short courses (<3 weeks) at low-moderate doses, tapering is unnecessary and steroids can be stopped abruptly, but for courses longer than 3 weeks or doses above 7.5 mg/day prednisone equivalent, gradual tapering is essential to prevent adrenal insufficiency 1, 2
Tapering is mandatory for any patient receiving more than 7.5 mg prednisone equivalent daily for more than 3 weeks, as HPA axis suppression should be anticipated in these circumstances 1, 2

The Endocrine Society suggests tapering rapidly from high doses to 10 mg/day within 4-8 weeks, as this initial phase primarily addresses disease control rather than HPA axis suppression 1, 4
Reduce by 5-10 mg per week until reaching 10 mg/day, then slow the taper significantly once approaching physiological doses 1, 4
The American Academy of Allergy, Asthma, and Immunology recommends reducing by 2.5 mg every 2-4 weeks until reaching 5 mg/day, then taper by 1 mg every 4 weeks until complete discontinuation 3, 4

For polymyalgia rheumatica, initial dose is 12.5-25 mg/day, taper to 10 mg/day within 4-8 weeks, then reduce by 1 mg every 4 weeks 1, 4
For inflammatory myopathies, start at 60-80 mg/day, taper by 10 mg every 2 weeks to 30 mg/day, then 5 mg every 2 weeks to 20 mg/day, then 2.5 mg every 2 weeks 4
For asthma exacerbations, use 40-60 mg/day for 5-10 days with no taper required for these short courses 3

If disease flare occurs, immediately return to the pre-relapse dose and maintain for 4-8 weeks before attempting a slower taper 1, 4
Monitor for both disease activity and adrenal insufficiency symptoms, with follow-up visits every 4-8 weeks in the first year, then every 8-12 weeks in the second year 1
For disease-specific monitoring, check monthly during tapering 4

All patients tapering steroids require supplemental glucocorticoids during acute illness or physiologic stress, with this requirement persisting up to 12 months after discontinuation in patients who received prolonged therapy 4
Use single morning dosing to minimize HPA axis suppression, except for prominent night pain on low doses 4
Elderly patients and those with diabetes, osteoporosis, or glaucoma require more cautious tapering due to increased adverse effect risk 1